4,361 to 4,370 of 8,623 Results
Apr 23, 2020 -
NTNU Intranasal Naloxone Trial (NINA-1) Study documents
Adobe PDF - 3.2 MB -
MD5: 8b4cd65e220676bfb371089df4dd65d4
Approval of protocol NINA-1 trial by The Regional Committee for Medical and Health Research Ethics (REC) in Norway |
Apr 23, 2020 -
NTNU Intranasal Naloxone Trial (NINA-1) Study documents
Adobe PDF - 215.7 KB -
MD5: 8b31c095c16a2690bb775cdaafc2e6f2
Original approval by The Norwegian Medicines Agency |
Apr 23, 2020 -
NTNU Intranasal Naloxone Trial (NINA-1) Study documents
Adobe PDF - 155.9 KB -
MD5: 90cf357930d8ea3bd0161b7b9c63acb4
Approval by Norwegian Medicines Agency protocol amendments version 3.3 dated 6th March 2020 |
Jan 22, 2021 -
NTNU Intranasal Naloxone Trial (NINA-1) Study documents
Adobe PDF - 2.8 MB -
MD5: 7532e8977d0d0b124c687ffbf546ff65
|
Jan 22, 2021 -
NTNU Intranasal Naloxone Trial (NINA-1) Study documents
Adobe PDF - 2.7 MB -
MD5: 1f4682b22b06bf258268f6571bcc4d35
|
Jan 22, 2021 -
NTNU Intranasal Naloxone Trial (NINA-1) Study documents
Adobe PDF - 5.5 MB -
MD5: fee64d5af2bdc7288eb0c0a6021c1d8c
|
Jan 22, 2021 -
NTNU Intranasal Naloxone Trial (NINA-1) Study documents
Adobe PDF - 322.5 KB -
MD5: 40444ddc7d97633e0371037d66ea897b
Example Case Report from from study kit |
Jan 22, 2021 -
NTNU Intranasal Naloxone Trial (NINA-1) Study documents
Adobe PDF - 134.9 KB -
MD5: dd6202ead5574532849bbb06c398ca5e
Example Serious Adverse Event form from study kit |
Jan 22, 2021 -
NTNU Intranasal Naloxone Trial (NINA-1) Study documents
Adobe PDF - 9.0 MB -
MD5: b7a8505210e9b0ba9fe678a51342676a
|
Jan 22, 2021 -
NTNU Intranasal Naloxone Trial (NINA-1) Study documents
Adobe PDF - 176.8 KB -
MD5: f2f6fa01fbb82a8647172dcccb905248
|
